Tucaresol
Tucaresol is an orally bioavailable immunopotentiatory drug that show to enhance T-helper-cell activity, with the induction of increased IL-2 and IFN-γ levels in mice and humans. Tucaresol has anti-HIV effect[1].
Product Specifications
CAS Number
[84290-27-7]
Product Name Alternative
BWA589C
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
HIV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Cancer; Infection
Assay Protocol
https://www.medchemexpress.com/tucaresol.html
Purity
98.95
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
OC(C(C=C1)=CC=C1COC2=C(C(O)=CC=C2)C=O)=O
Molecular Formula
C15H12O5
Molecular Weight
272.26
Precautions
H302, H315, H319, H335
References & Citations
[1]A C Smith, et al. Activity of the novel immunomodulatory compound tucaresol against experimental visceral leishmaniasis. Antimicrob Agents Chemother. 2000 Jun;44 (6) :1494-8.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6346445-01 0.1 mL
SET, NT (SET, Protein SET, HLA-DR-associated protein II, Inhibitor of granzyme A-activated DNase, PHAPII, Phosphatase 2A inhibitor I2PP2A, Template-activating factor I) (MaxLight 550)
Ask
View Details 
MBS6346445-02 5x 0.1 mL
SET, NT (SET, Protein SET, HLA-DR-associated protein II, Inhibitor of granzyme A-activated DNase, PHAPII, Phosphatase 2A inhibitor I2PP2A, Template-activating factor I) (MaxLight 550)
Ask
View Details 
MBS6324007-01 0.1 mL
NBPF8, NT (NBPF8, Neuroblastoma breakpoint family member 8) (MaxLight 490)
Ask
View Details MBS6324007-02 5x 0.1 mL
NBPF8, NT (NBPF8, Neuroblastoma breakpoint family member 8) (MaxLight 490)
Ask
View Details